Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages 924-929

  Zidan, Jamal ^a,b   Sikorsky, Natalya ^c   Basher, Walid ^a   Sharabi, Adi ^a   Friedman, Eitan ^d   Steiner, Mariana ^c  

^a Rebecca Sieff Government Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Lynn Medical Center   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARAB; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER STAGING; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; JEW; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR VOLUME; WOMEN'S HEALTH;

ARABS; BREAST NEOPLASMS; FEMALE; HUMANS; ISRAEL; JEWS; LYMPHATIC METASTASIS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN;

EID: 84862544349     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26431     Document Type: Article

References (40)

1. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA,. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005; 34: 405-12 (Pubitemid 40645331)
2. SEER program information accessed on April 2, 2007. From World Wide Web URL; Available at:.
3. Masi C, Olopade O,. Racial and ethnic disparities in breast cancer: a multilevel perspective. Med Clin N Am 2005; 89: 753-70. (Pubitemid 40755542)
4. Baron-Apel O., Breast cancer. In:, Green M, ed. The state of health in Israel 1999, publication no 213. Jerusalem: Israel Center for Disease Control. p 91-5.
5. Ministry of Health in Israel. Available at:.
6. Weinberg RA,. Tumor suppressor genes. Science 1991; 254: 1138-46. (Pubitemid 21917438)
7. Haenszel W,. Cancer mortality among the foreign born in the United States. J Natl Cancer Inst 1961; 26: 37-52.
8. Lannin D, Mathews H, Mitchel J, Swanson M, Swanson F, Edwards M,. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 1998; 279: 1801-7. (Pubitemid 28280252)
9. Parkin DM, Whelan SL, Ferlay J, Teppo L, eds. Cancer incidence in five continents, volume VIII. IARC Scientific Publication 2002; No. 155. Lyon (France): International Agency for Research on Cancer.
10. Nissan A, Spira RM, Hamburger T, Badrriyah M, Prus D, Cohen T, Hubert A, Freund HR, Peretz T,. Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am J Surg 2004; 188: 62-7. (Pubitemid 38823056)
11. Cross C, Harris J, Recht A,. Race, socioeconomic status, and breast carcinoma in the U.S. What have we learned from clinical studies? Cancer 2002; 95: 1988-99. (Pubitemid 35222180)
12. Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schäfer P, Sappino AP, Kurtz J, Neyroud-Caspar I, Bouchardy C,. Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 2005; 41: 1446-52. (Pubitemid 40826469)
13. de la Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, Durand JC, Pouillart P, Magdelenat H, Fourquet A,. Age as a prognostic factor in premenopausal breast carcinoma. Lancet 1993; 341: 1039-43. (Pubitemid 23114394)
14. Kuru B, Camlibel M, Gulcelik MA, Alagol H,. Prognostic factors affecting survival and disease free survival in lymph node-negative breast carcinomas. J Surg Oncol 2003; 83: 167-72. (Pubitemid 36807946)
15. D'Eredita' G, Giardina C, Martellotta M, Natale T, Ferrarese F,. Prognostic factors in breast cancer: the predictive value of the Nottingham prognostic index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer 2001; 37: 591-6. (Pubitemid 32261016)
16. Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK,. Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol 1999; 16: 95-103. (Pubitemid 29349855)
17. El Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Geara FB, Shamseddine AI,. Effects of young age at presentation on survival in breast cancer. BMC Cancer 2006; 6: 194.
18. Al-Kuraya K, Schraml P, Sheikh S, Amr S, Torhorst J, Tapia C, Novotny H, Spichtin H, Maurer R, Mirlacher M, Simon R, Sauter G,. Predominance of high-grade pathway in breast cancer development of Middle East women. Modern Pathology 2005; 18: 891-7. (Pubitemid 41059948)
19. UICC: International Union Against Cancer. TNM classification of malignant tumours, 6th edn. New York, NY: Wiley-Liss, 2002. p 131-41.
20. Ibrahim EM, al-Mulhim FA, al-Amri A, al-Muhanna FA, Ezzat AA, Stuart RK, Ajarim D,. Breast cancer in the eastern province of Saudi Arabia. Med Oncol 1998; 15: 241-7. (Pubitemid 29049188)
21. Ministry of Health. Cancer in Israel; Trends in Incidence and Mortality. Publication No. 310, 2008.
22. Central Bureau of Statistics. Jerusalem: Statistical Yearbook of Israel, 2004.
23. Haenzel W,. Migrant studies. In:, Schottenfeld D, Fraumeni JR, eds. Cancer epidemiology and prevention. Philadelphia: WB Saunders, 1982. p 194-9.
24. Sieri S, Krogh V, Pala V, Muti P, Micheli A, Evangelista A, Tagliabue G, Berrino F,. Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2004. 13: 567-72. (Pubitemid 38737892)
25. McTiernan A, Ulrich C, Slate S, Potter J,. Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 1998; 9: 487-509. (Pubitemid 29026912)
26. Jones BA, Kasi SV, Curnen MG, Owens PH, Dubrow R,. Severe obesity as as an expalnatory factor for the black/white difference in stage at diagnosis of breast cancer. Am J Epidemiol 1997; 146: 394-404. (Pubitemid 27377516)
27. Henquin N, Trostler N, Horn Y,. Nutritional risk factors and breast cancer in Jewish and Arab women. Cancer Nurs 1994; 17: 326-33. (Pubitemid 24255422)
28. Labidi SI, Mrad K, Mezlini A, Ouarda MA, Combes JD, Ben Abdallah M, Ben Romdhane K, Viens P, Ben Ayed F,. Inflammatory breast cancer in Tunisia in the era of multimodality therapy. Annal Oncol 2008; 19: 473-80. (Pubitemid 351325667)
29. Chia KS, Du WB, Sankaranarayanan R, Sankila R, Wang H, Lee J, Seow A, Lee HP,. Do younger female breast cancer patients have a poorer prognosis? Results from a population-based survival analysis. Int J Cancer 2004; 108: 761-5. (Pubitemid 38076409)
30. Miller BA, Hankey BF, Thomas TL,. Impact of sociodemografic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size of breast cancer in US women. Am J Epidemiol 2002; 155: 534-45. (Pubitemid 34208045)
31. Li CI, Malone KE, Daling JR,. Differences in breast cancer stage, treatment and survival by race and ethnicity. Arch Intern Med 2003; 163: 49-56. (Pubitemid 36091600)
32. Ikpatt OF, Dignan JJ, Khramtsov A, Grushko T, Fackenthal J, Sveen L, Nanda R, Ndoma-Egba R, Olopade OI,. Breast tumor morphometry in relation to race reveals significant differences among Nigerians, African-American and Caucasian Americans. Proc Am Soc Clin Oncol 2004; 23: 9567 (Abstract).
33. Zidan J, Dashkovsky I, Stayerman C, Basher W, Cozacov C, Hadary A,. Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease. Br J Cancer 2005; 93: 552-6. (Pubitemid 43079998)
34. Slichenmyer W, Fry D,. Anticancer therapy targeting the Erb B family of receptor tyrosine kinases. Semin Oncol 2001; 28: 67-79. (Pubitemid 33065112)
35. Ameyaw MM, Tayeb M, Thornton N, Folayan G, Tariq M, Mobarek A, Evans DA, Ofori-Adjei D, McLead HL,. Ethnic variation in HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J Hum Genet 2005; 47: 172-5. (Pubitemid 34496176)
36. Choi DH, Shin DB, Lee MH, Lee DW, Dhandapani D, Carter D, King BL, Haffty BG,. A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma. Cancer 2003; 98: 1587-1595. (Pubitemid 37238613)
37. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA,. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8. (Pubitemid 27208598)
38. Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA,. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 2007; 357: 115-123. (Pubitemid 47057729)
39. Kadouri L, Bercovich D, Elimelech A, Lerer I, Sagi M, Glusman G, Shochat C, Korem S, Hamburger T, Nissan A, Abu-Halaf N, Badrriyah M, et al,. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer 2007; 7: 14.
40. Charef-Hamza S, Trimeche M, Ziadi S, Amara K, Gaddas N, Mokni M, Sriha B, Yacoubi T, Korbi S,. Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer. Cancer Lett 2005; 224: 185-91. (Pubitemid 40725840)